Ogiyama_2017_Bioorg.Med.Chem_25_4817

Reference

Title : Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor - Ogiyama_2017_Bioorg.Med.Chem_25_4817
Author(s) : Ogiyama T , Yamaguchi M , Kurikawa N , Honzumi S , Terayama K , Nagaoka N , Yamamoto Y , Kimura T , Sugiyama D , Inoue SI
Ref : Bioorganic & Medicinal Chemistry , 25 :4817 , 2017
Abstract :

HSL inhibition is a promising approach to the treatment of dyslipidemia. As a result of re-optimization of lead compound 2, we identified novel compound 25a exhibiting potent inhibitory activity against HSL enzyme and cell with high selectivity for cholinesterases (AChE and BuChE). Reflecting its potent in vitro activity, compound 25a exhibited antilipolytic effect in rats at 1mg/kg p.o., which indicated that this novel compound is the most potent orally active HSL inhibitor. Moreover, compound 25a did not show bioactivation liability.

PubMedSearch : Ogiyama_2017_Bioorg.Med.Chem_25_4817
PubMedID: 28756012
Gene_locus related to this paper: human-LIPE

Related information

Gene_locus human-LIPE

Citations formats

Ogiyama T, Yamaguchi M, Kurikawa N, Honzumi S, Terayama K, Nagaoka N, Yamamoto Y, Kimura T, Sugiyama D, Inoue SI (2017)
Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor
Bioorganic & Medicinal Chemistry 25 :4817

Ogiyama T, Yamaguchi M, Kurikawa N, Honzumi S, Terayama K, Nagaoka N, Yamamoto Y, Kimura T, Sugiyama D, Inoue SI (2017)
Bioorganic & Medicinal Chemistry 25 :4817